Currently predicting for Thu, 2 May 2024

Trading levels for ALRN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.20 14.36 %
R2 5.00 9.91 %
R1 4.88 7.16 %
Current price: 4.55
Support S1 4.47 -1.74 %
S2 4.35 -4.49 %
S3 4.14 -8.94 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.35 17.58 %
R2 5.00 9.89 %
R1 4.75 4.40 %
Current price 4.55
Support S1 4.34 -4.62%
S2 4.25 -6.59%
S3 4.15 -8.75%

ALRN Predictions History

2 months ago
goynesq.236280 predicted that ALRN for Feb. 23rd is going

2 months ago
PredictionBot.Warren predicted that ALRN for Feb. 21st is going $4.61 (-1.10%)

2 months ago
PredictionBot.Kathy predicted that ALRN for Feb. 21st is going $4.55 (-2.51%)

2 months ago
goynesq.236280 predicted that ALRN for Feb. 21st is going

3 years ago
JS predicted that ALRN for 2021-02-16 is going $2.03 (1.00%)

3 years ago
Vic Chandrasma predicted that ALRN for 2021-02-16 is going

Rank:

3 years ago
JS predicted that ALRN for 2021-02-08 is going $2.11 (-0.94%)

3 years ago
JS predicted that ALRN for 2021-02-05 is going $2.06 (-5.94%)

3 years ago
Evan.Zaruba.8506 predicted that ALRN for 2021-01-25 is going $2.88 (29.73%)

Rank:

3 years ago
JS predicted that ALRN for 2020-11-13 is going $1.03 (-1.90%)

Click to get the best stock tips daily for free!

About Aileron Therapeutics Inc

Aileron Therapeutics Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... ALRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT